UPClytics
Alle Fälle anzeigen

ORD 3184/2025

·EP3797685: SYSTEMS AND METHODS FOR DISPLAY DEVICE AND SENSOR ELECTRONICS UNIT COMMUNICATION

Verfahrensdetails
Status
Verfahrensart
Verfahrensantrag
Kategorie
Verfahrensführungsanordnungen
Parteien
Kläger
Vertreter: Marcus Grosch (Quinn Emanuel Urquhart & Sullivan LLP); Johannes Bukow (Quinn Emanuel Urquhart & Sullivan LLP); Jérôme Kommer (Quinn Emanuel Urquhart & Sullivan LLP); Katrin Gerstenberg (Quinn Emanuel Urquhart & Sullivan LLP); Sebastian Scholz (Quinn Emanuel Urquhart & Sullivan LLP); Laurin Haasis (Quinn Emanuel Urquhart & Sullivan LLP); Peter Klusmann (Hoffmann Eitle); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)
Beklagte
Vertreter: Dietrich Kamlah (Taylor Wessing); Christian Lederer (Taylor Wessing); Gisbert Hohagen (Taylor Wessing); Wim Maas (Taylor Wessing); Eelco Bergsma (Taylor Wessing); François Pochart (August Debouzy)
Division
Court of Appeal
Richter
Technology
Healthcare Informatics
Sprache
Erste Entscheidung
24. Jan. 2025
Entscheidungen
  • 2025-01-24
    ZurückgenommenGeneric Order

    Court of Appeal order allowing withdrawal of the infringement appeal and counterclaim for revocation filed by DexCom against Abbott companies, pursuant to R. 265 RoP. The withdrawal was allowed, proceedings declared closed, and the impugned first-instance decision became ineffective. Court held that withdrawal may be filed in appeal proceedings, that withdrawal of a revocation counterclaim renders amendment requests ineffective, and that closure of proceedings renders the impugned decision ineffective.

    Rechtsfragen:Withdrawal of action (R. 265 RoP)Withdrawal in appeal proceedingsEffect of withdrawal of counterclaim for revocationReimbursement of court fees (R. 370.9 RoP)
Dokumente
  • D0BFB1E74E14EC72666408FF03CF2DE0_en.pdf2025-01-24ENGLISH
DexCom, Inc. v Abbott Laboratories — UPC ORD 3184/2025 | UPClytics